Gene-based association tests aggregate genotypes across multiple variants for each gene, providing 2 an interpretable gene-level analysis framework for genome-wide association studies (GWAS). Early 3 gene-based test applications often focused on rare coding variants; a more recent wave of gene-based 4 methods, e.g. TWAS, use eQTLs to interrogate regulatory associations. Regulatory variants are 5 expected to be particularly valuable for gene-based analysis, since most GWAS associations to 6 date are non-coding. However, identifying causal genes from regulatory associations remains 7 challenging and contentious. Here, we present a statistical framework and computational tool 8 to integrate heterogeneous annotations with GWAS summary statistics for gene-based analysis, 9 applied with comprehensive coding and tissue-specific regulatory annotations. We compare power 10 and accuracy identifying causal genes across single-annotation, omnibus, and annotation-agnostic 11 gene-based tests in simulation studies and an analysis of 128 traits from the UK Biobank, and find 12 that incorporating heterogeneous annotations in gene-based association analysis increases power 13 and performance identifying causal genes. 14 Genome-wide association studies (GWAS) have identified thousands of genetic loci associated 16 with complex traits (Welter et al. 2013); however, the biological mechanisms underlying these 17 associations are often poorly understood. Gene-based association tests can provide a more 18 interpretable analysis framework compared to single-variant analysis, interrogating association 19 at the gene level by aggregating genotypes across multiple variants for each gene. This strategy can 20 also increase power to detect association by aggregating small effects across variants, reducing the 21 burden of multiple testing, and weighting or filtering to prioritize functional variants (Neale and 22 Sham 2004; Sham and Purcell 2014).
Introduction
Basic gene-based test forms used in GAMBIT. Z k denotes the single-variant z-score association test statistic for variant k, with p-value p k = 1 − F χ 2 1 (Z 2 k ). Under the null hypothesis, each Z k is standard normal and Z is multivariate normal with correlation matrix R Z . w k denotes the weight assigned to variant k. Any real-valued weights can be used in L-form tests, whereas Q-form, ACAT-V, and the harmonic mean p-value (HMP) require non-negative weights. λ k denotes the k th eigenvalue of diag(w) 1/2 R Z diag(w) 1/2 , and each χ 2 1,k is i.i.d χ 2 1 . The location parameter µ = log m + 1 + γ + log(π/2), where m is the number of variants and γ is the Euler-Mascheroni constant.
Figure 1: GAMBIT Analysis Framework & Workflow
Broad overview of GAMBIT workflow. (1) GWAS association summary statistics (single-variant z-scores, or effect size estimates and standard errors) are cross-referenced and linked with multiple sets of functional annotations. (2) Annotated GWAS variants are cross-referenced with variants in a haplotype reference panel to estimate LD on-the-fly as needed. (3) GWAS summary statistics, annotations, and LD estimates are used to calculate stratified gene-based test statistics. (4) Stratified gene-based tests are combined for each gene to construct omnibus test statistics. GAMBIT supports multiple single-annotation test methods and multiple omnibus test methods to combine single-annotation tests; detailed statistical methods are provided in Materials and Methods.
Functional Annotation Data

Figure 2: Regulatory Annotation Tracks and Gene Weights
Illustration of primary regulatory annotation tracks used in GAMBIT gene-based analysis framework at the CELSR2 locus on chromosome 1. Top panel: Distance-to-transcription start site (dTSS) weights, calculated as w jk (α) = exp(−α|d jk |), where d jk is the number of base pairs between variant j and the TSS of gene k, shown for α = 10 −5 (solid lines), α = 5 × 10 −5 (dashed lines), and α = 10 −4 (dotted lines). Gene bodies are indicated by arrows and variant locations are marked in black at y = 0. Middle panel: enhancer-to-target-gene confidence weights. Weights are shown for enhancer variant and target gene, and unique enhancer elements are marked by black lines at y = 0. Lower panel: tissue-specific eVariant weights for each gene. eVariant tissues are differentiated by shape.
GWAS Simulations
however, the GAMBIT omnibus test was nearly as accurate, and had the second-highest performance 124 across simulation settings (Figure 3; Supplementary Figure 1 ). In practical applications, the causal 125 mechanisms underlying associations are unknown and often heterogeneous across loci; in this case, 126 we expect the GAMBIT omnibus testing strategy to be most accurate. 
127
Figure 4: GWAS Simulations: Statistical Power
Statistical power (proportion of simulation replicates in which gene-based p-value ≤ 2.5 × 10 −6 across loci; y-axis) for each gene-based testing approach (x-axis & color) stratified by locus heritability h 2 L (plot rows) when either coding, eQTL, enhancer, or UTR variants are causal (plot columns). Power is shown separately for causal genes and proximal genes (non-causal genes that are proximal to a causal gene, as defined in Materials and Methods). Ideally, gene-based tests should have high power for causal genes, and relatively lower power for proximal genes. Error bars show 95% confidence intervals for average power across loci. 
Analysis of GWAS Data from the UK Biobank
Figure 6: UK Biobank Analysis: Overlap Between Gene-Based Association Methods
Panel A: Total number of significant genes (p-value < 2.5e-6) for each method across all 128 traits. Unlike Figure 5 , gene-based associations in Figure 6 are not filtered or LD pruned, and a single significant GWAS variant can produce multiple significant gene-based associations for a given method. Here, a larger number of significant genes does not necessarily imply greater statistical power. Panel B: The i, j th heatmap element can be interpreted as the conditional probability that gene-based test i is significant given that gene-based test j is significant, which is estimated as the total number of overlapping significant genes between tests i and j divided by the total number of significant genes for test j. Omnibus tests detected significantly more associations than any other gene-based association 147 method considered ( Figure 5A ), and consistently detected more associations than other methods 148 across a wide range of traits and genetic architectures ( Figure 5B ). 
where m i is the number of variants in the i th regulatory element, w ik is the confidence weight 361 between element i and gene k, and Z i j is the j th variant in the i th regulatory element. 362 eQTL Weights. Given a vector of weights b kt to predict expression levels for gene k in a given 363 tissue or cell type t as a linear combination of normalized genotypes, the z-score TWAS test of 364 association between predicted expression level and GWAS trait is
where Z is the vector of single-variant GWAS z-scores and R Z is the correlation matrix of z-scores.
366
To aggregate test statistics across multiple tissues or cell-types, which we refer to as Cross-Tissue 367 TWAS (CT-TWAS), we considered three approaches:
here and elsewhere (without loss of generality). By fixing the residual variance σ 2 ε = 1 − τ 2 , we 430 can interpret τ 2 as the trait heritability, i.e. the proportion of trait variance due to genetic effects.
431
Single-variant GWAS association analysis aims to detect marginal associations between trait 432 and genotypes at individual variants rather than multiple variants jointly. The marginal effect of
where R k is k th row (or column) of the LD matrix R. We note that α k quantifies a statistical 
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We can write the vector of single-variant association statistics for variants k = 1, 2, ..., m as 671 Supplementary 
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Supplementary Figure 2 : UK Biobank: Sensitivity and Specificity of Gene Ranking Materials and Methods ROC and Precision-Recall curves for each gene-based association or ranking method across benchmark loci present in both HPO and ClinVar (54 loci in total). To aggregate results across benchmark loci and UK Biobank traits, we use standardized scores for each method calculated by dividing gene-based scores (e.g., -log 10 -p-values) by the maximum value at the corresponding locus. This procedure ensures that curves reflect performance ranking genes at each locus individually. We obtained similar results using the quantile rank of gene-based scores within each locus for each method rather than dividing by the maximum value.
